Results 111 to 120 of about 40,229 (203)

Cefepime and Linezolid Toxicity and Therapeutic Drug Monitoring [PDF]

open access: yes
While the clinical impact of antimicrobial TDM on efficacy is evident, the impact of TDM to avoid toxicity is less clear. Cefepime and linezolid are two last-line antimicrobials with serious toxicities associated with drug exposure. Further investigation
Lau, Cindy Cin-Ting
core  

Cefepime versus carbapenem for treating complicated urinary tract infection caused by cefoxitin-nonsusceptible ESCPM organisms: a multicenter, real-world study

open access: yesBMC Infectious Diseases
Background This investigation aimed to compare the efficacy of cefepime and carbapenem for complicated urinary tract infection (cUTI) caused by presumptive AmpC β-lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii ...
Liang Chen, Jie Hua, Xiaopu He
doaj   +1 more source

Development of cefepime‐induced encephalopathy in a patient with depression and rectal cancer: A case report

open access: yesNeuropsychopharmacology Reports
Background Cefepime, a fourth‐generation cephalosporin, has neurotoxic side effects such as encephalopathy. Baseline conditions, including blood–brain barrier (BBB) impairment and renal dysfunction, are known to associate with elevated central nervous ...
Junji Yamaguchi   +6 more
doaj   +1 more source

Implementing a Model-Informed Precision Dosing Service for Cefepime in a Quaternary Children's Hospital: A First-Year Experience. [PDF]

open access: yesTher Drug Monit
Morales Junior R   +6 more
europepmc   +1 more source

Clinical relevance of cefepime and taniborbactam against Gram-negative bacteria

open access: yes
Combination of cefepime and taniborbactamegységes, osztatlanáltalános ...
Tokuyama, Kayu
core  

Clinical, Microbiological and Genomic Characterization of OXA-48-Producing <i>Klebsiella pneumoniae</i> ST395 Circulating in a Secondary-Care Hospital in North-Eastern Italy, 2024-2025. [PDF]

open access: yesAntibiotics (Basel)
Giuliano S   +13 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy